10x Genomics, Inc.
TXG
$14.01
-$0.27-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.02% | -0.13% | -1.28% | 6.56% | 11.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.02% | -0.13% | -1.28% | 6.56% | 11.14% |
| Cost of Revenue | -12.02% | -10.69% | -6.40% | 18.22% | 48.65% |
| Gross Profit | 9.67% | 5.66% | 1.34% | 1.54% | -2.31% |
| SG&A Expenses | -0.31% | 1.04% | -0.02% | 2.28% | 5.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.80% | -3.16% | -1.86% | 3.91% | 10.84% |
| Operating Income | 23.32% | 12.34% | 3.64% | 4.56% | -9.85% |
| Income Before Tax | 65.99% | 40.29% | 28.57% | 19.52% | -39.77% |
| Income Tax Expenses | -19.60% | -50.83% | -22.24% | 38.59% | 20.97% |
| Earnings from Continuing Operations | 64.72% | 40.58% | 28.41% | 18.27% | -39.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.72% | 40.58% | 28.41% | 18.27% | -39.17% |
| EBIT | 23.32% | 12.34% | 3.64% | 4.56% | -9.85% |
| EBITDA | 26.62% | 13.05% | 4.65% | 8.49% | -6.13% |
| EPS Basic | 65.33% | 42.17% | 30.30% | 20.21% | -35.51% |
| Normalized Basic EPS | 27.71% | 15.64% | 5.09% | 11.02% | -2.37% |
| EPS Diluted | 65.41% | 41.98% | 30.10% | 19.98% | -35.80% |
| Normalized Diluted EPS | 27.70% | 15.64% | 5.09% | 11.02% | -2.37% |
| Average Basic Shares Outstanding | 2.72% | 2.67% | 2.81% | 3.00% | 3.16% |
| Average Diluted Shares Outstanding | 2.88% | 2.67% | 2.81% | 3.00% | 3.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |